Emord & Associates

ADDRESSES:
VIRGINIA (Firm HQ)
11808 Wolf Run Lane
Clifton, VA 20124

WASHINGTON D.C.
1050 Seventeenth Street, N.W.
Suite 600
Washington, D.C. 20036

ARIZONA
2730 S. Val Vista Drive
Suite 117
Gilbert, AZ 85295

Telephone: (202) 466-6937
Telecopier: (202) 466-6938

The following includes a representative sample of recent decisions, pleadings, and presentations.
PLEASE NOTE: THE DECISIONS PUBLISHED ON THIS WEB SITE ARE NOT AN ALL-INCLUSIVE LISTING OF ALL CASES INVOLVING EMORD AND ASSOCIATES AS COUNSEL. RESULTS DEPEND UPON A VARIETY OF FACTORS UNIQUE TO EACH CASE. THE RESULTS PUBLISHED HERE DO NOT GUARANTEE OR PREDICT A SIMILAR RESULT IN ANY FUTURE CASE UNDERTAKEN BY THE FIRM.

DECISIONS:
´ Nutraceutical Corp. v. Von Eschenbach
´ Nutraceutical Corp. v. Crawford
´ Pearson v. Shalala
´ Pearson v. Shalala, en banc
´ Pearson v. Shalala II
´ Pearson v. Thompson
´ Whitaker v. Thompson I
´ Whitaker v. Thompson II
´ Whitaker v. Thompson III

RECENT COMPLAINTS:
´ Saw Palmetto / BPH Complaint
´ B-Vitamin / Vascular Disease and E-Vitamin / Heart Disease Complaint
´ Medicinal Marijuana Complaint
´ Folic Acid Complaint
´ Antioxidant Complaint

RECENT BRIEFS:
´ Nutraceutical Corp. v. Von Eschenbach Appellees' Petition for Rehearing
´ Saw Palmetto / Memorandum in Support of Motion for Summary Judgment
´ Saw Palmetto/BPH Opposition To Motion To Dismiss
´ Medicinal Marijuana Application for Preliminary Injunction
´ Pearson Remand Application for Preliminary Injunction
´ Pearson Remand Memorandum in Support of Application for Preliminary Injunction
´ Pearson Remand Memorandum in Support of Motion to Supplement
´ Pearson Remand Memorandum in Support of Reply to Opposition
´ Folic Acid Motion for Preliminary Injunction and Memo in Support
´ Folic Acid / Reply to Opposition to Motion for Summary Judgment
´ Folic Acid / Reply to Opposition to Application for Preliminary Judgment
´ Folic Acid / Opposition to Motion to Dismiss
´ Folic Acid / Opposition to Petition for Reconsideration
´ Saw Palmetto / Reply to Opposition to Motion for Summary Judgment
´ Memorandum in Support of Application for Preliminary Injunction in the Antioxidant Case

RECENT COMMENTS/PETITIONS:
´ FDA grants qualified claims for calcium and colon/rectal cancer and polyps
´ FDA grants qualified claims for calcium and hypertension
´ Chromium Picolinate Petition Decision
´ The Coronary Heart Disease Risk Reducing Effects of N-3 Fatty Acids
´ Connor's Scientific References
´ Final Comments on Proposed CGMPs
´ Comments on Qualified Health Claims
´ Comments on FDA's Task Force on Consumer Health Information for Better Nutrition
´ FTC First Amendment Petition
´ Ephedra Comments
´ First Amendment Reply Comments
´ First Amendment Comments
´ Saw Palmetto / BPH Health Claim Petition
´ B-Vitamin / Vascular Disease Health Claim Petition
´ E-Vitamin / Heart Disease Health Claim Petition
´ Comments on Proposed GMPs for Dietary Supplements
´ Comments on Proposed Ephedra Regulations
´ Petition for Rulemaking Calling on FTC to Define Competent and Reliable Scientific Evidence
´ Comments to HCFA on Privacy Regulations
´ Comments on FDA's Significant Scientific Agreement Standard
´ Structure/Function Claims Proposed Rule

CONGRESSIONAL TESTIMONY:
´ Access to Medical Treatment (House Government Reform and Oversight Committee)

FDA TESTIMONY:
´ Pearson Implementation
´ NLEA and Health Claims to Treat or Mitigate Disease

COURT TRANSCRIPTS:
´ April 10, 2000, Pearson v. Shalala Preliminary Injunction Hearing
´ October 28, 2002, Whitaker v. Thompson Motions Hearing

RECENT SPEECHES:
´ The Destruction of Solo and Small Group Medical Practices by Medicare (Heritage Foundation)
´ Speech on FDA Violation of First Amendment (FDLI)

CONTRIBUTIONS:
´ *PEARSON & SHAW LITIGATION FUND:
Individuals and entities interested in making a financial contribution to the Pearson & Shaw Litigation Fund should send checks payable to "Pearson and Shaw Litigation Fund" at: Pearson and Shaw Litigation Fund c/o Emord & Associates, P.C., 1800 Alexander Bell Drive, Suite 200, Reston, VA 20191.

       Copyright © 2002 - 2007 Emord & Associates, P.C.